The Society for Medical Decision Making (SMDM) presented its highest career honor, the 2026 Career Achievement Award, to Professor Uwe Siebert, MPH, ...
The U.S. Food and Drug Administration is speeding up its review of an oral medicine for sickle cell disease that may fill a ...
SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of ...
Agios stock jumps after the FDA accepts and grants priority review to its sNDA for mitapivat in sickle cell disease, with a ...
On July 1, 2026, Vertex Pharmaceuticals announced that the FDA approved an expanded indication for CASGEVY (exagamglogene autotemcel) to ...
Enables standardized inpatient hospital billing for QUELIMMUNE® (SCD-PED) therapy Universal code paves the way for billing of future potential SCD therapies requiring renal replacement therapy DENVER, ...
Fulcrum Therapeutics has scrapped its sole clinical-stage program after the FDA took a hard line on the modality following the recent withdrawal of Ipsen’s Tazverik from the U.S. market. Ipsen ...
The LMP Capital and Income Fund (SCD) is a closed-end fund that aims to provide its investors with a high level of current income along with capital appreciation through investments in a portfolio ...
The expanded infrastructure will enable production of IR solutions for high-end applications, including area dominance, airborne payloads, space systems, and large-scale defense platforms. Defense ...
India accounts for the second-highest prevalence of sickle cell disease (SCD) globally, following sub-Saharan Africa. However, not much research has been done, and no stigma measurement tool was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results